Class Action Lawsuit Reminder: Levi & Korsinsky notifies Rocket Pharmaceuticals, Inc. (RCKT)

Investors in Rocket Pharmaceuticals, Inc. (RCKT) have been reminded by Levi & Korsinsky of an upcoming deadline for a class-action lawsuit. The deadline for investors to participate in the lawsuit is August 11, 2025. This alert was issued in New York, NY.

The lawsuit revolves around allegations that Rocket Pharmaceuticals, Inc. made misleading statements and failed to disclose important information. Investors who suffered losses as a result of investing in Rocket Pharmaceuticals, Inc. from March 2021 to February 2021 may be eligible to participate in the lawsuit.

It is alleged that Rocket Pharmaceuticals, Inc. failed to disclose that the company’s processes for manufacturing adeno-associated virus (“AAV”) gene therapy products were deficient. This led to contamination risks, which in turn caused multiple clinical hold regulatory concerns.

The lawsuit further alleges that Rocket Pharmaceuticals, Inc. was not forthcoming about a material weakness in its internal controls over financial reporting. This weak control framework led to the misstatements of the company’s financial condition and performance.

Investors who want to join the class-action lawsuit against Rocket Pharmaceuticals, Inc. have until August 11, 2025, to do so. By this date, investors need to seek the court’s appointment as a lead plaintiff.

In the lawsuit, the lead plaintiff will work with a legal team to ensure the rights of the investor class are protected and that a fair and just resolution is reached.

If you are a Rocket Pharmaceuticals, Inc. investor who has suffered financial losses in the stated timeframe, you may be eligible to join this class-action lawsuit. It is crucial to act quickly and meet the August 11, 2025, deadline in order to participate.

Remember, the securities litigation process can be complex, but the law provides protection for investors affected by misleading or false information disseminated by companies. If you believe you have been affected by Rocket Pharmaceuticals, Inc.’s alleged misconduct, it is important to seek legal counsel and consider joining the class-action lawsuit before the deadline passes.

By taking action and participating in the lawsuit, investors have the opportunity to seek redress for their losses and hold companies accountable for their actions. Make sure to consult with legal experts or representatives to understand your rights and options regarding this class-action lawsuit against Rocket Pharmaceuticals, Inc.

August 11, 2025, is the deadline for investors to join the class-action lawsuit against Rocket Pharmaceuticals, Inc. Don’t miss this opportunity to potentially recover losses suffered as a result of the company’s alleged misconduct.